NYSE:WAT - Waters Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $200.10
  • Forecasted Upside: -12.02 %
  • Number of Analysts: 11
  • Breakdown:
  • 4 Sell Ratings
  • 7 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$227.45
▲ +0.71 (0.31%)
1 month | 3 months | 12 months
Get New Waters Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WAT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WAT

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$200.10
▼ -12.02% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Waters in the last 3 months. The average price target is $200.10, with a high forecast of $235.00 and a low forecast of $145.00. The average price target represents a -12.02% upside from the last price of $227.45.
Hold
The current consensus among 11 investment analysts is to hold stock in Waters. This rating has held steady since May 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 6 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 6 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 6 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 6 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 5 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 4 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 4 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 4 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 4 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$235.00Medium
i
10/28/2020Stifel NicolausBoost Price TargetHold$220.00 ➝ $230.00Medium
i
10/28/2020Smith Barney CitigroupBoost Price Target$180.00 ➝ $185.00Low
i
10/28/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$230.00 ➝ $235.00Low
i
10/28/2020SVB LeerinkBoost Price TargetMarket Perform$225.00 ➝ $230.00Low
i
7/29/2020Stifel NicolausBoost Price TargetHold$180.00 ➝ $220.00High
i
7/29/2020SVB LeerinkBoost Price TargetMarket Perform$195.00 ➝ $225.00High
i
7/29/2020CitigroupBoost Price TargetSell$150.00 ➝ $180.00High
i
7/28/2020Needham & Company LLCInitiated CoverageSellHigh
i
Rating by Stephen Unger at Needham & Company LLC
7/28/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ NeutralLow
i
7/16/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$175.00 ➝ $225.00Medium
i
4/29/2020Bank of AmericaLower Price TargetUnderperform$160.00 ➝ $145.00High
i
4/29/2020Stifel NicolausBoost Price TargetHold$176.00 ➝ $180.00Medium
i
4/29/2020SVB LeerinkLower Price TargetMarket Perform$210.00 ➝ $195.00High
i
4/28/2020Needham & Company LLCInitiated CoverageSellHigh
i
Rating by Stephen Unger at Needham & Company LLC
4/28/2020UBS GroupLower Price TargetNeutral$223.00 ➝ $212.00Low
i
4/2/2020Stifel NicolausLower Price TargetHold$210.00 ➝ $176.00Low
i
3/30/2020Wells Fargo & CompanyLower Price TargetUnderweight$210.00 ➝ $180.00Medium
i
3/26/2020BarclaysLower Price TargetUnderweight$186.00 ➝ $172.00High
i
Rating by Jack Meehan at Barclays PLC
3/20/2020CitigroupLower Price TargetSell$190.00 ➝ $150.00Medium
i
2/4/2020Needham & Company LLCReiterated RatingSellHigh
i
1/8/2020Needham & Company LLCDowngradeHold ➝ UnderperformMedium
i
1/7/2020Wells Fargo & CompanyInitiated CoverageUnderweight$215.00High
i
1/6/2020CitigroupInitiated CoverageSell$190.00Medium
i
1/3/2020Needham & Company LLCInitiated CoverageHold$177.00Medium
i
1/3/2020Bank of AmericaUpgradeUnderperform ➝ NeutralMedium
i
12/4/2019BTIG ResearchDowngradeBuy ➝ NeutralLow
i
11/14/2019Stifel NicolausInitiated CoverageHold$210.00Medium
i
10/29/2019Needham & Company LLCReiterated RatingHoldHigh
i
10/9/2019BarclaysDowngradeEqual Weight ➝ Underweight$210.00 ➝ $195.00Low
i
7/16/2019Bank of AmericaDowngradeNeutral ➝ UnderperformLow
i
6/12/2019Cleveland ResearchDowngradeNeutral ➝ UnderperformMedium
i
5/30/2019Wolfe ResearchInitiated CoverageUnderperform ➝ UnderperformLow
i
4/24/2019UBS GroupLower Price TargetNeutral ➝ Neutral$248.00 ➝ $230.00Low
i
4/24/2019Robert W. BairdLower Price TargetNeutral ➝ Neutral$211.00 ➝ $209.00Low
i
4/24/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$218.00 ➝ $210.00Low
i
1/25/2019BarclaysReiterated RatingHold$200.00Medium
i
1/24/2019BTIG ResearchBoost Price TargetBuy$260.00Medium
i
1/24/2019Robert W. BairdDowngradeOutperform ➝ Neutral$191.00 ➝ $211.00Medium
i
1/3/2019Bank of AmericaUpgradeUnderperform ➝ NeutralHigh
i
Rating by Derik De Bruin at Bank of America Co.
1/2/2019Needham & Company LLCInitiated CoverageHold ➝ Hold$177.00High
i
12/12/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$185.00 ➝ $180.00Low
i
12/9/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$200.83Low
i
Rating by David Kostin at The Goldman Sachs Group, Inc.
11/30/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$185.00 ➝ $180.00Medium
i
Rating by Patrick B Donnelly at The Goldman Sachs Group, Inc.
10/24/2018UBS GroupLower Price TargetNeutral ➝ Neutral$210.00 ➝ $200.00High
i
Rating by Daniel Brennan at UBS Group AG
10/24/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$200.00 ➝ $190.00High
i
10/24/2018JPMorgan Chase & Co.Lower Price TargetNeutral ➝ Neutral$200.00 ➝ $185.00High
i
10/11/2018Cleveland ResearchUpgradeSell ➝ NeutralHigh
i
10/10/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$204.00 ➝ $211.00Medium
i
10/9/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$210.00Low
i
10/8/2018SVB LeerinkDowngradeOutperform ➝ Market PerformHigh
i
Rating by Puneet Souda at SVB Leerink LLC
7/25/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$201.00 ➝ $212.00Medium
i
7/25/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$205.00 ➝ $204.00Low
i
7/17/2018Janney Montgomery ScottDowngradeBuy ➝ Neutral$230.00 ➝ $211.00Medium
i
Rating by Paul Knight at Janney Montgomery Scott
7/16/2018Bank of AmericaDowngradeNeutral ➝ Underperform$190.00Medium
i
7/13/2018Morgan StanleyBoost Price TargetEqual Weight$200.00 ➝ $205.00High
i
6/14/2018Cleveland ResearchDowngradeNeutral ➝ UnderperformMedium
i
4/25/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$208.00 ➝ $200.00Medium
i
4/25/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$218.00 ➝ $200.00Low
i
4/25/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$220.00 ➝ $201.00Low
i
4/25/2018Jefferies Financial GroupReiterated RatingHold$200.00Medium
i
4/25/2018SVB LeerinkSet Price TargetBuy$230.00 ➝ $214.00Medium
i
Rating by Puneet Souda at SVB Leerink LLC
4/25/2018CowenReiterated RatingHold$215.00Medium
i
4/11/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$237.00 ➝ $218.00Low
i
1/25/2018BTIG ResearchReiterated RatingBuyLow
i
Rating by Sung Ji Nam at BTIG Research
1/24/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$202.00 ➝ $208.00N/A
i
1/24/2018Janney Montgomery ScottBoost Price TargetBuy ➝ Buy$200.00 ➝ $230.00N/A
i
1/24/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.00N/A
i
1/24/2018Robert W. BairdBoost Price TargetOutperform ➝ Outperform$219.00 ➝ $220.00N/A
i
1/24/2018CitigroupBoost Price TargetNeutral ➝ Neutral$190.00 ➝ $223.00N/A
i
1/23/2018William BlairReiterated RatingOutperformLow
i
Rating by A. Murphy at William Blair
1/8/2018BarclaysReiterated RatingHold$202.00Medium
i
1/5/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$230.00Medium
i
Rating by Sung Ji Nam at BTIG Research
1/3/2018Evercore ISIInitiated CoverageIn-Line$198.00Medium
i
12/4/2017Morgan StanleyUpgradeUnderweight ➝ Equal Weight$192.00High
i
11/10/2017Bank of AmericaBoost Price TargetNeutral$192.00 ➝ $202.00N/A
i
11/3/2017CowenReiterated RatingHold$190.00N/A
i
10/25/2017CitigroupReiterated RatingNeutral$180.00N/A
i
10/25/2017BarclaysBoost Price TargetEqual Weight$188.00 ➝ $193.00N/A
i
10/25/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$199.00 ➝ $200.00N/A
i
10/25/2017Robert W. BairdBoost Price TargetOutperform$196.00 ➝ $199.00N/A
i
10/9/2017Cleveland ResearchDowngradeBuy ➝ NeutralN/A
i
10/6/2017Morgan StanleyReiterated RatingUnderweight ➝ Underweight$183.00 ➝ $192.00N/A
i
9/26/2017The Goldman Sachs GroupInitiated CoverageHold$180.00Low
i
8/31/2017Jefferies Financial GroupReiterated RatingHold$175.00Low
i
7/27/2017Jefferies Financial GroupReiterated RatingHold$175.00Low
i
7/26/2017Morgan StanleyReiterated RatingUnderweight$174.00 ➝ $183.00Low
i
7/21/2017Bank of AmericaReiterated RatingNeutral$180.00 ➝ $192.00Low
i
7/14/2017CowenReiterated RatingHold$190.00Medium
i
7/14/2017Jefferies Financial GroupReiterated RatingHold$170.00Low
i
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 ➝ $205.00Low
i
7/10/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$183.00 ➝ $194.00High
i
5/1/2017Janney Montgomery ScottUpgradeNeutral ➝ Buy$185.00 ➝ $200.00Medium
i
4/29/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$166.00 ➝ $183.00Medium
i
4/26/2017BarclaysSet Price TargetHold$160.00Low
i
Rating by Jack Meehan at Barclays PLC
4/26/2017CowenBoost Price TargetMarket Perform$160.00 ➝ $175.00Low
i
4/25/2017Cantor FitzgeraldReiterated RatingBuy$170.00 ➝ $190.00Low
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
3/3/2017Evercore ISIDowngradeHold ➝ UnderperformN/A
i
3/3/2017Jefferies Financial GroupBoost Price TargetHold$147.00 ➝ $150.00N/A
i
3/3/2017Cantor FitzgeraldReiterated RatingOverweight$170.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
1/24/2017Cantor FitzgeraldSet Price TargetBuy$170.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$160.00N/A
i
1/9/2017BarclaysReiterated RatingHold$148.00N/A
i
Rating by Jack Meehan at Barclays PLC
1/6/2017William BlairUpgradeMarket Perform ➝ OutperformN/A
i
Rating by A. Murphy at William Blair
12/8/2016Cantor FitzgeraldSet Price TargetBuy$170.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
11/10/2016SVB LeerinkReiterated RatingOutperform$163.00N/A
i
Rating by P. Souda at SVB Leerink LLC
10/28/2016Jefferies Financial GroupReiterated RatingHold$150.00 ➝ $145.00N/A
i
10/25/2016Cantor FitzgeraldReiterated RatingBuy$170.00N/A
i
7/27/2016CitigroupBoost Price TargetNeutral$138.00 ➝ $160.00N/A
i
7/27/2016BarclaysBoost Price TargetEqual Weight$130.00 ➝ $157.00N/A
i
Rating by Jack Meehan at Barclays PLC
7/27/2016Jefferies Financial GroupBoost Price TargetHold$128.00 ➝ $150.00N/A
i
7/27/2016MizuhoBoost Price TargetNeutral$130.00 ➝ $145.00N/A
i
7/26/2016Evercore ISIBoost Price TargetHold$140.50 ➝ $154.00N/A
i
7/26/2016Cantor FitzgeraldBoost Price TargetBuy$163.00 ➝ $173.00N/A
i
4/27/2016MizuhoBoost Price TargetNeutral$125.00 ➝ $130.00N/A
i
4/26/2016SVB LeerinkReiterated RatingHoldN/A
i
Rating by Dan Leonard at SVB Leerink LLC
4/26/2016Morgan StanleyReiterated RatingSellN/A
i
Rating by Steve Beuchaw at Morgan Stanley
4/5/2016Bank of AmericaDowngradeBuy ➝ Neutral$137.00N/A
i
3/23/2016The Goldman Sachs GroupBoost Price Target$140.00N/A
i
3/1/2016BarclaysInitiated CoverageEqual Weight$125.00N/A
i
1/27/2016William BlairReiterated RatingMarket PerformN/A
i
1/27/2016UBS GroupLower Price TargetNeutral$144.00 ➝ $137.00N/A
i
1/27/2016The Goldman Sachs GroupLower Price TargetNeutral$135.00 ➝ $134.00N/A
i
1/27/2016Deutsche Bank AktiengesellschaftLower Price TargetHold$137.00 ➝ $130.00N/A
i
1/27/2016Cantor FitzgeraldReiterated RatingBuy$163.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
1/7/2016CowenBoost Price Target$140.00N/A
i
1/6/2016Avondale PartnersInitiated CoverageOutperform$155.00N/A
i
1/6/2016Deutsche Bank AktiengesellschaftInitiated CoverageHold$137.00N/A
i
12/8/2015The Goldman Sachs GroupBoost Price Target$128.00 ➝ $140.00N/A
i
12/2/2015Cantor FitzgeraldUpgradeBuy$163.00N/A
i
Rating by Bryan Brokmeier at Cantor Fitzgerald
(Data available from 11/27/2015 forward)
Waters logo
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.
Read More

Today's Range

Now: $227.45
$225.83
$228.73

50 Day Range

MA: $219.90
$200.09
$232.65

52 Week Range

Now: $227.45
$154.39
$245.68

Volume

7,100 shs

Average Volume

546,895 shs

Market Capitalization

$14.11 billion

P/E Ratio

28.33

Dividend Yield

N/A

Beta

0.97